CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today announced that Harry Rein has resigned as a director of the Company, effective August 4, 2008. Mr. Rein is a General Partner with Foundation Medical Partners�L.P., which was an early investor in CardioNet, and Mr. Rein served as a director of CardioNet since January�2006. Randy Thurman, Executive Chairman of CardioNet, will serve as a member of the Audit Committee and as a member and as Chairman of the Compensation, Nominating and Corporate Governance Committee, positions formerly held by Mr. Rein. CardioNet�s Board of Directors would like to thank Mr. Rein for his service and numerous contributions that have contributed to the company�s success. About CardioNet CardioNet, Inc. is a leading provider of ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual�s health. CardioNet�s initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders, with a solution that it markets as the CardioNet System. More information can be found at http://www.cardionet.com.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more HeartBeam Charts.
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more HeartBeam Charts.